British American Tobacco p.l.c. (BTI): what the price assumes

boothcheck covers British American Tobacco p.l.c. (BTI) but does not put one priced-in number on it: here the defensible answer is the evidence rather than a point estimate. boothcheck publishes no house fair value, target price, or buy/sell rating. Narrative composed 2026-07-25.

Generated: 2026-08-10 · Exported: 2026-08-12 · Source: https://boothcheck.com/report/BTI

Headline

What The Price Assumes (Inversion)

The assumption today's price embeds, recovered by inverting the valuation.

The operating-margin figure is value-band context at year 12: derived from the framework's value band, a separate calculation — not part of the priced-in solve.

The price sits below what even a 5%/yr operating-profit decline would warrant; the inversion reports a bound, not a solved growth path.

Solve inputs: computed at a 7% cost of capital with 4% terminal growth over a 5-year stage (computed at the 7% minimum rate; the CAPM rate 6.8% sits below it).

Reconcile: at the x-ray's 9.3% required return this reads ~4.2%/yr; the models below use their own rates.

How unusual the bet is: within-range (limited comparison data)

Valuation X-Ray

The price is supported by asset-based and relative-multiple value, while earnings-power/growth-DCF land below the price. A value/asset-supported name, not a pure growth bet.

How the valuation models price the stock relative to the market price. Price/FV above 1.0 means the market pays more than that lens defends (expensive); at or below 1.0 the lens can defend the price.

Families that justify the price: Asset, Relative Families that call it expensive: Earnings, Growth

The models below discount at their own flat-beta convention rates (cost of equity 9.3%, WACC 9.3%); the inversion above states its own rate.

Per-Model Detail (n=16)

Solvency

Bullet Takeaways

• Combustible cigarettes still supply 79% of revenue, and the business works by pushing price and mix up faster than volume falls: in the U.S. last year price and mix added 12.3% while volume dropped 7.7%, and revenue rose anyway.
• The sharpest threat is the black market rather than the regulator, and Australia is the live demonstration, with the company estimating that illicit product "now accounts for more than 65% of the combustibles industry volume" and regional adjusted profit from operations down 17.9% at constant rates.
• Half-year numbers arrive on 30 July 2026, and the closed period running up to them is already covered by a standing buyback arrangement through 29 July.

Bull Case

Start with what the balance sheet is being asked to do. British American Tobacco carries 41.3 billion dollars of net borrowings, which sounds heavy until you notice that interest is covered about six times over and the company is not burning cash. Management is spending that headroom two ways at once: paying the borrowings down and retiring its own equity. The share count has fallen about 1.1% a year since the end of 2021, and the board committed to 1.3 billion pounds of buybacks for 2026 alongside an interim dividend of 245.04 pence per ordinary share declared in February, paid in four equal quarterly instalments. A management team that genuinely believed the end was near would hoard the cash.

What lets the balance sheet do that is a pricing mechanic most consumer businesses would envy. Group cigarette volume fell 7.9% in 2025, to 465 billion sticks, which in almost any other industry would read as a revenue collapse. Group revenue was 25,610 million pounds against 25,867 million a year earlier, and up 2.1% once the currency translation is stripped out. In the U.S., the largest region, combustibles revenue actually rose 1.4% to 9,218 million pounds, because "price/mix (including excise duty drawback) of +12.3% more than offset a 7.7% reduction in volume". Fewer customers, more revenue. That is what price inelasticity looks like on an income statement.

The profitability that follows has no real analogue in the wider staples cohort. PG reports an operating margin of 23.2% and PEP 14.8%, the two strongest in the comparison set, which also holds KR at 1.3%, TGT at 4.5% and SYY at 3.6%. Tobacco economics sit well above that entire range, and they sit there without the reinvestment burden a food or household-products business carries just to defend shelf space.

The second thing worth understanding is that an open-ended liability has just been closed. Canadian tobacco claims ran through court-supervised proceedings under the Companies' Creditors Arrangement Act from March 2019, and the approved plan delivers a "release to ITCAN, BAT p.l.c. and all related companies for all past, present and future tobacco claims in Canada". The load-bearing word there is future. An upfront payment funds the settlement trust out of cash, investments and court deposits already held in Canada, and the remaining provision is expected to unwind within five years. The company did not negotiate a discount on the bill. It ended the bill.

The newer categories are where the equity story wants attention, and the honest read is mixed rather than empty. Grizzly nicotine pouches, pushed into wider U.S. distribution in August 2025, reached 1.8% national share by December, drawing consumers who were already migrating out of the company's own traditional oral products. That is a defensive win rather than a conquest, but defence is worth real money when the alternative is watching a whole category walk to somebody else's brand.

Bear Case

The price rests on one assumption and everything else is decoration: that price and mix keep outrunning volume for long enough to matter. Combustibles are 79% of revenue, and the combustible base is not stabilising. Group cigarette volume fell 7.9% in 2025 to 465 billion sticks. The offset is price, applied year after year to a shrinking population of smokers. A holder is underwriting how many more rounds of that trade the remaining customers absorb.

The mechanism that ends the trade is already visible, and it is not the regulator. It is the black market. In Australia the company estimates the illicit segment "now accounts for more than 65% of the combustibles industry volume", and the regional line shows the consequence: adjusted profit from operations at constant rates down 17.9%, to 1,793 million pounds. High excise plus thin enforcement does not stop people smoking. It moves them to sellers who pay no duty, honour no age limit and answer to nobody. The same pattern runs through U.S. vapour, where group volume fell 8.8% and revenue 6.4% on what the filing attributes to the proliferation of illicit single-use products.

The replacement categories are not yet carrying the weight the story assigns them. Traditional oral revenue was 1,043 million pounds in 2025, down 4.5%, with volume down 9.1% to 5.5 billion sticks. Vapour, heated products, modern oral and traditional oral together account for about a fifth of revenue, and one of the four is shrinking faster than combustibles. Management's own pay design registers how contested this is: New Categories revenue growth is a named performance condition in the long-term incentive plan, sitting beside earnings per share, operating cash flow, total shareholder return and net turnover. When a company has to pay its executives specifically to grow a category, the category is not growing on its own.

The valuation methods that normalise earnings rather than annualise the most recent year are unimpressed. The price sits more than double the earnings-power methods' central estimate, and comfortably above where the forward-looking cash-flow methods land. Only the asset-value and peer-multiple lenses reach it. That shape has a plain reading: the price is defensible on what the company owns and on what comparable staples businesses fetch, and not on what its earning power, measured across a full cycle, would fund.

The balance sheet is comfortable today, and it is comfortable on today's profit. Net borrowings of 41.3 billion dollars sit at about 3.13 times operating profit on the last reported annual figures, with interest covered about six times. Both ratios share a denominator, and the denominator is precisely the thing this case says erodes. Outside the operating business the company holds roughly 2.0 billion dollars of equity stakes, about 1.5% of its market value: a real floor under the downside, and a thin one.

The annual filing is unsentimental about where this goes wrong. Disproportionate regulation of combustible products, it notes, reaches past sales into the group's ability to execute its strategy at all, and an unfavourable litigation outcome could expose it to "substantial liability, which may take the form of ongoing payments". Canada is settled. The precedent Canada set is not.

Valuation

Take the price as given and read backwards from it. At $60.96 the market is paying roughly 14 times what the whole company earns before interest and tax, for a business it plainly expects to shrink. That is low enough that the price already sits below what a steadily declining stream of operating profit would warrant. Worth pausing on: the market is not asking this company to grow. It is asking it to shrink more slowly than the price has already conceded.

The methods used to triangulate a business like this disagree in a readable pattern. The price sits about 14% above the asset-value methods' central estimate, close enough to call them aligned. The peer-multiple methods land above the price outright. The earnings-power lens and the forward-looking cash-flow methods land well under it, the price sitting more than double the earnings-power methods' central estimate. That combination is a value read rather than a growth bet: what holds the price up is the asset base and what comparable staples businesses fetch, not projected cash generation.

The split between those groups is a statement about which years you count, not a contradiction. The earnings-power method builds its income base from a five-year average of operating profit with one-off charges added back, and that window contains the impairment and settlement years. So the earning power it works from sits far below what the company reported for its most recent full year. Whether that is prudence or distortion is the real analytical question here, and it decides whether the stock is cheap or correctly priced for decay.

The composition underneath the multiple is stark. Combustibles are 79% of revenue; vapour 6%, modern oral 5%, heated products 4%, traditional oral 4%, everything else 3%. The 79% funds the dividend, the buyback, the borrowings and the attempt to replace itself.

Set against the staples cohort, profitability is the outlier rather than the multiple. PG at a 23.2% operating margin and PEP at 14.8% are the strongest in the comparison set, which also contains KR at 1.3% and SYY at 3.6%. Tobacco sits above that whole range. A business earning at that rate on this multiple is the market pricing duration, not quality.

Solvency bounds the downside rather than adding to the case. Gross borrowings run to 46.3 billion dollars against 5.1 billion of liquid assets, leaving net borrowings of 41.3 billion; interest is covered about six times and the company is not burning cash. The share count has come down about 1.1% a year since the end of 2021, which is buyback deployment showing up in the one place it cannot be dressed up. The balance sheet can carry a declining business. It has no say in how fast the decline runs.

Catalysts

Half-year results are scheduled for 30 July 2026. The First Half Pre-Close Trading Update on 2 June said the company remained on track for full-year guidance, set in February at 3% to 5% revenue growth and 4% to 6% growth in adjusted profit from operations, both at constant currency. The line inside that print worth reading first is the U.S., where both combustibles share and vapour volume moved the wrong way last year.

Capital returns are running to a published schedule rather than at management's discretion. The board declared an interim dividend of 245.04 pence per ordinary share on 12 February 2026, payable in four equal instalments of 61.26 pence in May, August and November 2026 and February 2027. Alongside it sits a 1.3 billion pound buyback programme for 2026, with shares bought and cancelled in the week of 13 to 17 July and a standing arrangement with UBS covering purchases through the closed period ending 29 July.

Two slower items sit behind those. The Canadian settlement provision is expected to unwind within five years, which turns a decades-old contingency into a scheduled cash cost. And enforcement against illicit single-use vapour in the U.S. is the external variable with the most leverage on the reported numbers: the company flagged encouraging early signs on that front in its latest annual filing, and if enforcement holds, the volume line that fell 8.8% last year is the first one to turn.

Peer Cohorts (Per Segment, With Filing Citations)

Core business (reported)

• UNFI (UNITED NATURAL FOODS, INC.)
• FY2025 10-K: …some or all of its purchases from us, our business, financial condition or results of operations may be materially and adversely affected. Our business is characterized by low margins, which are sensitive to inflationary and deflationary pressures, and intense competition and consolidation in the grocery industry,…
• FY2025 10-K: …compete with retailers that maintain or develop self-distribution systems, as well as companies that offer services in digital advertising, fulfillment and delivery services, health and wellness and financial services. The primary competitive factors in the wholesale business include price, service level, product…
• DEO (DIAGEO plc)
• FY2025 20-F: …of (1.1)%, partially offset by hyperinflation adjustments and organic net sales growth. Organic net sales growth of 1.7% was driven by organic volume growth of 0.9% and positive price/mix of 0.8%. Excluding the impact of the Cîroc transaction, organic net sales growth was 1.5%, with 0.8% volume growth and 0.7%…
• FY2025 20-F: …products for other group companies and includes the production sites in the United Kingdom, Ireland, Italy, Guatemala and Mexico, as well as comprises the global procurement function, is considered a key intersegmental operation instead of a separate operating segment . 156 Diageo Form 20-F 2025 FINANCIAL STATEMENTS…
• MDLZ (Mondelez International, Inc.)
• FY2025 10-K: …in this environment and/or our hedging strategies may not protect us from increases in cocoa costs, which could result in a significant adverse impact on our profitability. We address higher commodity costs and currency impacts primarily through hedging, higher pricing and manufacturing and overhead cost control. We…
• FY2025 10-K: …resulting in fewer, larger customers. Large retail customers and customer alliances can delist our products or reduce the shelf space allotted to our products and demand lower pricing, increased promotional programs or longer payment terms. Retail customers might also adopt these tactics in their dealings with us in…
• USFD (US FOODS HOLDING CORP.)
• FY2025 10-K: …we experience competition from cash-and-carry operations, commercial wholesale outlets, warehouse clubs and grocery stores that serve the commercial foodservice marketplace. We also experience competition from online direct food wholesalers and other retailers, and competitors that are utilizing technology, including…
• FY2025 10-K: …customers and, as a result, our customers may turn to other distributors. Furthermore, any changes to the pricing practices of our suppliers, including the reduction or elimination of promotional allowances, could result in a material adverse effect on our business, financial condition and results of operations. Our…
• ABEV (AMBEV S.A.)
• FY2025 20-F: …customer service. Consolidation has significantly increased the capital base and geographic reach of our competitors in some of the markets in which we operate. Concurrently, competition in the beverage industry is expanding and the market is becoming more fragmented, complex and sophisticated as consumer preferences…
• FY2025 20-F: …them could adversely affect the sale and consumption of our products and harm our business, results of operations, cash flows or financial condition to the extent consumers and customers change their purchasing patterns. Key brand names are used by us, our subsidiaries, associates and joint ventures, and licensed to…
• KHC (Kraft Heinz Co)
• FY2025 10-K: …and development efforts focus on achieving the following four objectives: • product innovations, renovations, and new technologies to meet changing consumer needs, drive growth, and support our environmental and sustainability goals; • world-class and uncompromising food safety, quality, and consistency; • superior,…
• FY2025 10-K: …offerings. Our principal competitors in these categories are manufacturers and retailers with their own branded and private label products. We compete based on product innovation, price, product quality, nutritional value, service, taste, convenience, brand recognition and loyalty, effectiveness of marketing and…
• PM (Philip Morris International Inc.)
• FY2025 10-K: …cases, if any. Legal defense costs are expensed as incurred. Consolidated Operating Results Net revenues, significant expenses, and operating income by segment were as follows: (in millions) Europe SSEA, CIS & MEA EA, AU & PMI GTR Americas Total For the Year Ended December 31, 2025 Net revenues $ 17,111 $ 12,051 $…
• FY2025 10-K: …CBD), in line with applicable regulatory requirements, though any revenue related to cannabinoids is expected to be negligible in the near to medium term. We use the term net revenues to refer to our operating revenues from the sale of our products, including shipping and handling charges billed to customers, net of…
• DG (DOLLAR GENERAL CORP)
• FY2025 10-K: …service offerings, product sourcing and supply chain capacity, in-stock consistency, customer service, ease of shopping experience (including but not limited to various modes of shopping, including online alternatives and delivery), promotional activity, employees, and market share. We compete with discount stores…
• FY2025 10-K: 03; We seek to drive profitable sales growth through initiatives aimed at increasing customer traffic and average transaction amount. Historically, sales in our consumables category, which tend to have lower gross margins, have been the key drivers of net sales and customer traffic, while sales in our non-consumables…

Methodology Note

• Priced-in inversion: the valuation is inverted on the current price to recover the operating-income growth, duration, and steady-state margin the price embeds (ROE for financials, FFO growth for REITs).
• Valuation x-ray: the valuation models, grouped into four families (asset, earnings, relative, growth). Each model is expressed as a price/FV ratio (distance from price), not a point fair-value estimate. The spread across families is the disagreement.
• Solvency: net cash/debt, net-debt-to-NOPAT, interest coverage, and share-count CAGR from EDGAR financials (net debt / FFO and fixed-charge coverage for REITs; regulatory-capital framing for financials).
• Peer cohorts: per-segment comparables with deep-linkable SEC filing citations.

Fundamentals sourced from SEC EDGAR filings. Current price from Databento. The priced-in inversion and valuation x-ray are computed by the boothcheck engine; narrative composed by AI from the structured data.